等待開盤 09-06 09:30:00 美东时间
+1.650
+2.43%
Analysts' ratings for Henry Schein (NASDAQ:HSIC) over the last quarter vary fro...
08-26 20:01
Evercore ISI Group analyst Elizabeth Anderson upgrades Henry Schein (NASDAQ:HSIC) from In-Line to Outperform and announces $83 price target.
08-26 19:21
(来源:医趋势) 8月7日,美国医疗器械企业HistoSonics宣布,一个由私募和公募投资者组成的联盟已完成对其多数股权的收购,此次收购由公司管理层主导。...
08-11 12:05
今日重点评级关注:HC Wainwright & Co.:维持FibroGen"买入"评级,目标价从10美元升至43美元;摩根大通:维持Cogent Biosciences"超配"评级,目标价从29美元升至30美元
08-08 09:34
6 analysts have expressed a variety of opinions on Henry Schein (NASDAQ:HSIC) o...
08-07 05:03
UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and lowers the price target from $75 to $70.
08-06 23:47
Henry Schein shares are trading lower after the company reported worse-than-exp...
08-06 02:00
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32
Henry Schein (NASDAQ:HSIC) underwent analysis by 6 analysts in the last quarter...
07-26 04:00